ARTICLE | Company News
ContraFect, Rockefeller University deal
December 6, 2010 8:00 AM UTC
The university granted ContraFect an exclusive, worldwide license to eight patents covering lysin enzymes to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA), group B stre...